NASC - Can B Corp
0.0125
0.001 8.000%
Share volume: 1,061
Last Updated: 03-27-2026
Wholesale/Wholesale – Drugs & Drug Proprietaries:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$0.01
0.00
0.09%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 07-16-2024 | 08-19-2024 | 11-19-2024 | |
| Total revenue | 369.096 K | 272.287 K | 15.269 K | |
| Cost of revenue | 1.193 M | 665.471 K | 415.816 K | |
| Gross profit | -824.065 K | -393.184 K | -400.547 K | |
| 52.29% | -1.87% | |||
| Operating expenses | 1.688 M | 1.174 M | 2.432 M | |
| Selling general and admin | 1.688 M | 1.174 M | 2.432 M | |
| Research and development | 0.000 | 0.000 | 0.000 | |
| Total expenses | 4.831 M | 1.174 M | 2.432 M | |
| -75.70% | 107.22% | |||
| Operating income | -5.655 M | -1.567 M | -2.833 M | |
| Ebit | -5.655 M | -1.565 M | -2.832 M | |
| Pretax income | -6.161 M | -2.029 M | -3.263 M | |
| -67.07% | 60.83% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -6.161 M | -2.029 M | -3.263 M | |
| 67.07% | -60.83% |